Review of laboratory-developed tests (LDTS) and in vitro diagnostics (IVDS) support IDIQ
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75F40122D00007
- Awardee
-
Propharma Group LLC UEI N6C8UMMHCB15
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Task orders
- 1 $4,172,983 obligated
Award facts
- Combined order value
- $4,172,983 Current and potential, with all options
- Last date to order 93% complete
- IDV ceiling 17% used
- $25,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- Q701 Specialized Medical Support
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Health and Human Services Food and Drug Administration awarded an indefinite delivery contract to Propharma Group, LLC (doing business as Acadeus) with a potential value of $25 million. The contract provides review of Laboratory-Developed Tests and In Vitro Diagnostics Support through March 6, 2027.
A $7.736 million firm fixed price delivery order was also awarded for the period of March 2, 2022 through September 6, 2024 in Silver Spring, Maryland. Under this delivery order, Propharma Group will support the FDA's review of Laboratory Developed Tests and In Vitro Diagnostics as the prime contractor. No set-aside provisions were specified for either the indefinite delivery contract or associated delivery order.
The contracts aim to procure professional services and subject matter expertise related to the FDA's evaluation and regulation of Laboratory Developed Tests and In Vitro Diagnostics. As the named agency, the FDA requires assistance and advisory support for these medical product categories within its statutory purview. The awarded contracts and delivery order establish Propharma Group as the provider of these specialized review functions for the duration specified.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Review of laboratory-developed tests (LDTS) and in vitro diagnostics (IVDS) support to #1 | Food and Drug Administration | $4,172,983 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Novation Agreement | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75F40122D00007?
75F40122D00007 was awarded to Propharma Group LLC by Food and Drug Administration (Department of Health and Human Services) on March 7, 2022.
How much is contract 75F40122D00007 worth?
Orders under 75F40122D00007 have obligated $4,172,983. 75F40122D00007's own ceiling is $25,000,000.
How many orders have been placed under contract 75F40122D00007?
1 order has been placed under 75F40122D00007, the latest on March 2, 2022.
Who can order from contract 75F40122D00007?
75F40122D00007 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75F40122D00007 competed?
The extent of competition for 75F40122D00007 was not competed. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV